Dual Regulatory Roles of Phosphatidylinositol 3-Kinase in IFN Signaling1

PI3K is activated by the type I and II IFN receptors, but its precise role in the generation of IFN responses is not well understood. In the present study we used embryonic fibroblasts from mice with targeted disruption of the genes encoding for both the p85α and p85β regulatory subunits of PI3′-kinase (p85α−/−β−/−) to precisely define the role of PI3K in the control of IFN-induced biological responses. Our data demonstrate that PI3K plays dual regulatory roles in the induction of IFN responses by controlling both IFN-α- and IFN-γ-dependent transcriptional regulation of IFN-sensitive genes and simultaneously regulating the subsequent initiation of mRNA translation for such genes. These processes include the Isg15, Cxcl10, and/or Irf7 genes, whose functions are important in the generation of the biological effects of IFNs. Consistent with this, the induction of IFN antiviral responses is defective in double p85α/p85β knockout cells. Thus, integration of signals via PI3K is a critical event during engagement of the IFN receptors that complements both the transcriptional activity of Jak-STAT pathways and controls initiation of mRNA translation.

[1]  L. Platanias,et al.  Role of the Akt pathway in mRNA translation of interferon-stimulated genes , 2008, Proceedings of the National Academy of Sciences.

[2]  N. Sonenberg,et al.  Translational control of the innate immune response through IRF-7 , 2008, Nature.

[3]  R. Coffman,et al.  PI3K is critical for the nuclear translocation of IRF-7 and type I IFN production by human plasmacytoid predendritic cells in response to TLR activation , 2008, The Journal of experimental medicine.

[4]  R. Kaur,et al.  Activation of Nonreceptor Tyrosine Kinase Bmx/Etk Mediated by Phosphoinositide 3-Kinase, Epidermal Growth Factor Receptor, and ErbB3 in Prostate Cancer Cells* , 2007, Journal of Biological Chemistry.

[5]  D. McKay,et al.  Phosphatidylinositol 3′-Kinase Is a Critical Mediator of Interferon-γ-Induced Increases in Enteric Epithelial Permeability , 2007, Journal of Pharmacology and Experimental Therapeutics.

[6]  K. Knobeloch,et al.  IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses , 2007, Proceedings of the National Academy of Sciences.

[7]  N. Sonenberg,et al.  Regulatory Effects of Mammalian Target of Rapamycin-activated Pathways in Type I and II Interferon Signaling* , 2007, Journal of Biological Chemistry.

[8]  D. Grandér,et al.  Phosphoinositide 3-kinase regulates a subset of interferon-alpha-stimulated genes. , 2007, Experimental cell research.

[9]  G. Stark,et al.  Complex modulation of cell type-specific signaling in response to type I interferons. , 2006, Immunity.

[10]  A. Reder,et al.  Therapeutic role of beta-interferons in multiple sclerosis. , 2006, Pharmacology & therapeutics.

[11]  L. Platanias Introduction: interferon signals: what is classical and what is nonclassical? , 2005, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[12]  L. Platanias,et al.  The PI3' kinase pathway in interferon signaling. , 2005, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[13]  A. Verma,et al.  Role of the p38 mitogen-activated protein kinase pathway in cytokine-mediated hematopoietic suppression in myelodysplastic syndromes. , 2005, Cancer research.

[14]  N. Hay,et al.  The Akt-mTOR tango and its relevance to cancer. , 2005, Cancer cell.

[15]  B. McManus,et al.  Gamma Interferon-Inducible Protein 10 Induces HeLa Cell Apoptosis through a p53-Dependent Pathway Initiated by Suppression of Human Papillomavirus Type 18 E6 and E7 Expression , 2005, Molecular and Cellular Biology.

[16]  L. Platanias Mechanisms of type-I- and type-II-interferon-mediated signalling , 2005, Nature Reviews Immunology.

[17]  S. Parmar,et al.  Role of protein kinase C-δ (PKC-δ) in the generation of the effects of IFN-α in chronic myelogenous leukemia cells , 2005 .

[18]  Hideo Negishi,et al.  IRF-7 is the master regulator of type-I interferon-dependent immune responses , 2005, Nature.

[19]  Sheila M. Thomas,et al.  Role of Phosphoinositide 3-Kinase Regulatory Isoforms in Development and Actin Rearrangement , 2005, Molecular and Cellular Biology.

[20]  Michael G. Kharas,et al.  ABL oncogenes and phosphoinositide 3-kinase: mechanism of activation and downstream effectors. , 2005, Cancer research.

[21]  Ming Yan,et al.  Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection , 2004, Nature Medicine.

[22]  L. Platanias,et al.  Interferon-gamma engages the p70 S6 kinase to regulate phosphorylation of the 40S S6 ribosomal protein. , 2004, Experimental cell research.

[23]  G. G. Choudhury A Linear Signal Transduction Pathway Involving Phosphatidylinositol 3-Kinase, Protein Kinase Cϵ, and MAPK in Mesangial Cells Regulates Interferon-γ-induced STAT1α Transcriptional Activation* , 2004, Journal of Biological Chemistry.

[24]  D. Levy,et al.  Role of p38α Map Kinase in Type I Interferon Signaling* , 2004, Journal of Biological Chemistry.

[25]  J. Dennis,et al.  Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study. , 2003, JAMA.

[26]  N. Sonenberg,et al.  Activation of the p70 S6 Kinase and Phosphorylation of the 4E-BP1 Repressor of mRNA Translation by Type I Interferons* , 2003, Journal of Biological Chemistry.

[27]  J. Lord,et al.  Inhibition of Neutrophil Apoptosis by Type 1 IFN Depends on Cross-Talk Between Phosphoinositol 3-Kinase, Protein Kinase C-δ, and NF-κB Signaling Pathways1 , 2003, The Journal of Immunology.

[28]  A. Verma,et al.  Activation of Protein Kinase Cδ by IFN-γ1 , 2003, The Journal of Immunology.

[29]  J. Prieto,et al.  Interferon beta promotes survival in primary astrocytes through phosphatidylinositol 3-kinase , 2003, Journal of Neuroimmunology.

[30]  Guo-Ping Zhou,et al.  Triggering the Interferon Antiviral Response Through an IKK-Related Pathway , 2003, Science.

[31]  G. Feldman,et al.  A PI‐3 kinase‐dependent, Stat1‐independent signaling pathway regulates interferon‐stimulated monocyte adhesion , 2003, Journal of leukocyte biology.

[32]  A. Verma,et al.  Cutting Edge: Activation of the p38 Mitogen-Activated Protein Kinase Signaling Pathway Mediates Cytokine-Induced Hemopoietic Suppression in Aplastic Anemia1 , 2002, The Journal of Immunology.

[33]  Lewis C Cantley,et al.  The phosphoinositide 3-kinase pathway. , 2002, Science.

[34]  D. Aaronson,et al.  A Road Map for Those Who Don't Know JAK-STAT , 2002, Science.

[35]  A. Verma,et al.  Protein Kinase C-δ (PKC-δ) Is Activated by Type I Interferons and Mediates Phosphorylation of Stat1 on Serine 727* , 2002, The Journal of Biological Chemistry.

[36]  G. Stark,et al.  Roles of Phosphatidylinositol 3-Kinase in Interferon-γ-dependent Phosphorylation of STAT1 on Serine 727 and Activation of Gene Expression* , 2001, The Journal of Biological Chemistry.

[37]  Amit Verma,et al.  The p38 MAPK Pathway Mediates the Growth Inhibitory Effects of Interferon-α in BCR-ABL-expressing Cells* , 2001, The Journal of Biological Chemistry.

[38]  B. Hallberg,et al.  Interferon-α Promotes Survival of Human Primary B-Lymphocytes via Phosphatidylinositol 3-Kinase , 2001 .

[39]  L. Pfeffer,et al.  Interferon α/β Promotes Cell Survival by Activating Nuclear Factor κB through Phosphatidylinositol 3-Kinase and Akt* , 2001, The Journal of Biological Chemistry.

[40]  L. Platanias,et al.  Interferon-dependent activation of the serine kinase PI 3'-kinase requires engagement of the IRS pathway but not the Stat pathway. , 2000, Biochemical and biophysical research communications.

[41]  L. Platanias,et al.  Signaling pathways activated by interferons. , 1999, Experimental hematology.

[42]  G. Stark,et al.  How cells respond to interferons. , 1998, Annual review of biochemistry.

[43]  K. Alitalo,et al.  The Bmx tyrosine kinase induces activation of the Stat signaling pathway, which is specifically inhibited by protein kinase Cdelta. , 1997, Blood.

[44]  M. White,et al.  The IRS-pathway operates distinctively from the Stat-pathway in hematopoietic cells and transduces common and distinct signals during engagement of the insulin or interferon-alpha receptors. , 1997, Blood.

[45]  I. Kerr,et al.  Janus Kinase-dependent Activation of Insulin Receptor Substrate 1 in Response to Interleukin-4, Oncostatin M, and the Interferons* , 1997, The Journal of Biological Chemistry.

[46]  J. Darnell STATs and gene regulation. , 1997, Science.

[47]  M. White,et al.  Activation of the phosphatidylinositol 3-kinase serine kinase by IFN-alpha. , 1997, Journal of immunology.

[48]  C. Glass,et al.  Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[49]  M. White,et al.  The Type I Interferon Receptor Mediates Tyrosine Phosphorylation of Insulin Receptor Substrate 2 (*) , 1996, The Journal of Biological Chemistry.

[50]  M. White,et al.  Interferon-α Engages the Insulin Receptor Substrate-1 to Associate with the Phosphatidylinositol 3′-Kinase (*) , 1995, The Journal of Biological Chemistry.

[51]  J. Darnell,et al.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. , 1994, Science.

[52]  S. Baron,et al.  The interferons. Mechanisms of action and clinical applications. , 1991, JAMA.

[53]  M. White,et al.  Activation of the Phosphatidylinositol 3-Kinase Serine Kinase by 1 FNa ’ , 2001 .

[54]  L. Platanias,et al.  Activation of the p 38 Mitogen-activated Protein Kinase by Type I Interferons , 1999 .

[55]  K C Zoon,et al.  Interferons and their actions. , 1987, Annual review of biochemistry.

[56]  Interferon (cid:1) -induced Apoptosis in Tumor Cells Is Mediated through the Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Signaling Pathway* , 2022 .

[57]  G. Tellides,et al.  Interferon- (cid:1) Induces Fas Trafficking and Sensitization to Apoptosis in Vascular Smooth Muscle Cells via a PI3K- and Akt-Dependent Mechanism , 2022 .